Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.

ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.

Jang JY, Lee YS, Jeon YK, Lee K, Jang JJ, Kim CW.

Exp Mol Med. 2013 Jan 10;45:e3. doi: 10.1038/emm.2013.1.

2.

ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells.

Baik SH, Lee J, Lee YS, Jang JY, Kim CW.

Exp Mol Med. 2016 Mar 25;48:e222. doi: 10.1038/emm.2015.126.

3.

ANT2 suppression by shRNA may be able to exert anticancer effects in HCC further by restoring SOCS1 expression.

Jang JY, Jeon YK, Lee CE, Kim CW.

Int J Oncol. 2013 Feb;42(2):574-82. doi: 10.3892/ijo.2012.1736. Epub 2012 Dec 13.

PMID:
23242177
4.

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.

Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W.

Br J Cancer. 2010 Oct 12;103(8):1215-20. doi: 10.1038/sj.bjc.6605895. Epub 2010 Sep 14.

5.

Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.

Li WF, Dai H, Ou Q, Zuo GQ, Liu CA.

Tumour Biol. 2016 May;37(5):5885-95. doi: 10.1007/s13277-015-4456-1. Epub 2015 Nov 21.

PMID:
26589417
6.
7.

MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.

Xiao F, Zhang W, Chen L, Chen F, Xie H, Xing C, Yu X, Ding S, Chen K, Guo H, Cheng J, Zheng S, Zhou L.

J Transl Med. 2013 Aug 22;11:195. doi: 10.1186/1479-5876-11-195.

8.

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.

Oncogene. 2012 Jul 12;31(28):3357-69. doi: 10.1038/onc.2011.500. Epub 2011 Nov 7.

PMID:
22056881
9.

MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.

Shen G, Rong X, Zhao J, Yang X, Li H, Jiang H, Zhou Q, Ji T, Huang S, Zhang J, Jia H.

Carcinogenesis. 2014 Dec;35(12):2748-55. doi: 10.1093/carcin/bgu208. Epub 2014 Oct 3.

PMID:
25280563
11.

MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.

Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Su C, Chen J.

Cancer Lett. 2013 Sep 1;337(2):226-36. doi: 10.1016/j.canlet.2013.05.007. Epub 2013 May 14.

PMID:
23684551
12.

Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.

Zhang J, Cheng J, Zeng Z, Wang Y, Li X, Xie Q, Jia J, Yan Y, Guo Z, Gao J, Yao M, Chen X, Lu F.

Oncotarget. 2015 Dec 8;6(39):42040-52. doi: 10.18632/oncotarget.5969.

13.

MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.

Du C, Lv Z, Cao L, Ding C, Gyabaah OA, Xie H, Zhou L, Wu J, Zheng S.

J Transl Med. 2014 Sep 22;12:259. doi: 10.1186/s12967-014-0259-1.

14.

miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.

Xiao ZD, Jiao CY, Huang HT, He LJ, Zhao JJ, Lu ZY, Liu LX.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4039-44. eCollection 2014.

15.

MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.

Lang Q, Ling C.

Biochem Biophys Res Commun. 2012 Sep 21;426(2):247-52. doi: 10.1016/j.bbrc.2012.08.075. Epub 2012 Aug 23.

PMID:
22940133
16.

Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer.

Tao J, Ji J, Li X, Ding N, Wu H, Liu Y, Wang XW, Calvisi DF, Song G, Chen X.

Oncotarget. 2015 Mar 30;6(9):6977-88.

17.

MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.

Jiang J, Zhang Y, Guo Y, Yu C, Chen M, Li Z, Tian S, Sun C.

Oncotarget. 2015 Mar 20;6(8):6359-72.

18.

MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.

Huang GH, Shan H, Li D, Zhou B, Pang PF.

Cell Biochem Funct. 2017 Mar;35(2):98-104. doi: 10.1002/cbf.3252. Epub 2017 Mar 5.

PMID:
28261837
19.

MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.

Zhao G, Wang T, Huang QK, Pu M, Sun W, Zhang ZC, Ling R, Tao KS.

World J Gastroenterol. 2016 Jun 21;22(23):5364-73. doi: 10.3748/wjg.v22.i23.5364.

20.

Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.

Xie BH, He X, Hua RX, Zhang B, Tan GS, Xiong SQ, Liu LS, Chen W, Yang JY, Wang XN, Li HP.

Cancer Biomark. 2016;16(3):405-13. doi: 10.3233/CBM-160579.

PMID:
27062697

Supplemental Content

Support Center